Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Epidemiology, Burden, and Attributable Risks of Infective Endocarditis in Iran and Its Provinces: From 1990 to 2019 Publisher Pubmed



Ajam A1, 2 ; Shobeiri P1 ; Keykhaei M1, 3 ; Moghaddam SS1 ; Momtazmanesh S1 ; Masinaei M1 ; Esfahani Z1, 4 ; Rezaei N1, 5 ; Naderian M1 ; Aminorroaya A1 ; Rashidi MM1 ; Rezaei N1, 5 ; Larijani B5 ; Malakan Rad E6 Show All Authors
Authors
  1. Ajam A1, 2
  2. Shobeiri P1
  3. Keykhaei M1, 3
  4. Moghaddam SS1
  5. Momtazmanesh S1
  6. Masinaei M1
  7. Esfahani Z1, 4
  8. Rezaei N1, 5
  9. Naderian M1
  10. Aminorroaya A1
  11. Rashidi MM1
  12. Rezaei N1, 5
  13. Larijani B5
  14. Malakan Rad E6
  15. Farzadfar F1, 5
Show Affiliations
Authors Affiliations
  1. 1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Research Department, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Feinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States
  4. 4. Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  5. 5. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Pediatric Cardiology, Children's Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Cardiology Published:2022


Abstract

Background: Endocarditis is a potentially life-threatening infectious disease associated with significant morbidity and mortality and an escalating incidence in recent decades. In this study, as a part of the global burden of disease (GBD) 2019 study, we intend to report endocarditis burden in Iran at national and provincial levels from 1990 to 2019. Method: This study was conducted using GBD 2019 study data on endocarditis from 1990 to 2019. We gathered incidence, prevalence, disability-adjusted life years (DALYs), and mortality rates in Iran and its 31 provinces by sex and age groups as epidemiological indices for endocarditis burden. Further decomposition analysis was also performed to delineate the endocarditis new cases trend. Results: On the country scale, age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate were (16.5 (95% uncertainty interval 13.7 to 19.8), 3.4 (2.9 to 4.1), 0.6 (0.5 to 0.9), and 14.4 (12.0 to 21.1) in 2019, respectively. Decomposition analysis showed that only 59.2% of the overall new cases increase (114.1%) was caused by the incidence rate change. All estimated age-standardized rates were higher in men in 1990 and 2019 with a ratio of 1.1–1.5. Conclusion: The ASIR and ASPR of endocarditis increased, and the ASMR and age-standardized DALYs rate declined over the past 30 years in Iran, nearly all the provinces followed the same pattern with North Khorasan having the Highest ASIR, ASPR, ASMR, and DALYs rates in both years. High systolic blood pressure (SBP) had the greatest attributed burden among risk factors. © 2022 Elsevier B.V.
Related Docs
View other Related Docs
1. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
2. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the Gbd Study 2019, Journal of the American Heart Association (2024)
3. Global, Regional, and National Burden and Quality of Care Index of Endocarditis: The Global Burden of Disease Study 1990–2019, European Journal of Preventive Cardiology (2022)
4. Global, Regional, and National Burden of Bone Fractures in 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2021)
5. Global, Regional, and National Sex-Specific Burden and Control of the Hiv Epidemic, 1990–2019, for 204 Countries and Territories: The Global Burden of Diseases Study 2019, The Lancet HIV (2021)
6. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
7. Global, Regional, and National Progress Towards Sustainable Development Goal 3.2 for Neonatal and Child Health: All-Cause and Cause-Specific Mortality Findings From the Global Burden of Disease Study 2019, The Lancet (2021)
8. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (54)
Mohammad Ali Mansournia (35)
Other Related Docs
9. Estimating Mortality and Disability in Peru Before the Covid-19 Pandemic: A Systematic Analysis From the Global Burden of the Disease Study 2019, Frontiers in Public Health (2023)
10. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
11. Measuring Routine Childhood Vaccination Coverage in 204 Countries and Territories, 1980–2019: A Systematic Analysis for the Global Burden of Disease Study 2020, Release 1, The Lancet (2021)
12. Prevalence, Years Lived With Disability, and Trends in Anaemia Burden by Severity and Cause, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)
13. Global, Regional, and National Mortality Due to Unintentional Carbon Monoxide Poisoning, 2000–2021: Results From the Global Burden of Disease Study 2021, The Lancet Public Health (2023)
14. Low Bone Mineral Density, a Neglected Condition in North Africa and Middle East: Estimates From the Global Burden of Disease Study, 1990–2019, Osteoporosis International (2023)
15. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
16. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
17. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
18. Injury Burden in Individuals Aged 50 Years or Older in the Eastern Mediterranean Region, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2022)
19. Measuring the Availability of Human Resources for Health and Its Relationship to Universal Health Coverage for 204 Countries and Territories From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
20. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
21. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
22. The Unfinished Agenda of Communicable Diseases Among Children and Adolescents Before the Covid-19 Pandemic, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study 2019, The Lancet (2023)
23. Levels and Trends of Maternal Mortality and Morbidity by Cause in North Africa and Middle East, 1990 to 2019: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
24. Burden of Chronic Obstructive Pulmonary Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019, The BMJ (2022)
25. Global, Regional, and National Burden of Rheumatoid Arthritis, 1990–2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2023)
26. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
27. Mapping Age- and Sex-Specific Hiv Prevalence in Adults in Sub-Saharan Africa, 2000–2018, BMC Medicine (2022)
28. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
29. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, Chest (2022)
30. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019, Cancer Medicine (2023)
31. Comparative Analysis of Infective Endocarditis in Hemodialysis Versus Non-Hemodialysis Patients in Iran: Implications for Clinical Practice and Future Research, BMC Cardiovascular Disorders (2024)
32. Global, Regional, and National Burden of Respiratory Tract Cancers and Associated Risk Factors From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Respiratory Medicine (2021)
33. Global, Regional, and National Incidence of Six Major Immune-Mediated Inflammatory Diseases: Findings From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
34. Global, Regional, and National Burden of Allergic Disorders and Their Risk Factors in 204 Countries and Territories, From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Allergy: European Journal of Allergy and Clinical Immunology (2023)
35. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
36. The Burden of Neck Pain Among Adults Aged 70 Years and Older in Iran, 1990–2019, Health Science Reports (2023)
37. Burden of Tension-Type Headache in the Middle East and North Africa Region, 1990-2019, Journal of Headache and Pain (2022)
38. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
39. Attributable Disease Burden Related to Low Bone Mineral Density in Iran From 1990 to 2019: Results From the Global Burden of Disease 2019, Archives of Osteoporosis (2022)
40. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, European Journal of Preventive Cardiology (2022)
41. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990A€“2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet (2021)
42. Global, Regional, and National Burden of Cancers Attributable to Tobacco Smoking in 204 Countries and Territories, 1990–2019, Cancer Medicine (2022)
43. Global, Regional, and National Burden of Cancers Attributable to Excess Body Weight in 204 Countries and Territories, 1990 to 2019, Obesity (2022)
44. Burden of Tracheal, Bronchus, and Lung Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990 to 2019, Journal of Thoracic Oncology (2021)
45. National and Sub-National Burden and Trend of Type 1 Diabetes in 31 Provinces of Iran, 1990–2019, Scientific Reports (2023)
46. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
47. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
48. National and Subnational Burden of Female and Male Breast Cancer and Risk Factors in Iran From 1990 to 2019: Results From the Global Burden of Disease Study 2019, Breast Cancer Research (2023)
49. Global, Regional, and National Burden of Migraine in 204 Countries and Territories, 1990 to 2019, Pain (2022)
50. National and Subnational Burden of Stroke in Iran From 1990 to 2019, Annals of Clinical and Translational Neurology (2022)